Tatva Chintan Pharma Chem Limited

NSEI:TATVA 주식 보고서

시가총액: ₹20.0b

Tatva Chintan Pharma Chem 미래 성장

Future 기준 확인 5/6

Tatva Chintan Pharma Chem is forecast to grow earnings and revenue by 70.5% and 30% per annum respectively. EPS is expected to grow by 70.5% per annum. Return on equity is forecast to be 9.4% in 3 years.

주요 정보

70.5%

수익 성장률

70.5%

EPS 성장률

Chemicals 수익 성장21.0%
매출 성장률30.0%
향후 자기자본 수익률9.4%
애널리스트 커버리지

Low

마지막 업데이트28 Oct 2024

최근 미래 성장 업데이트

Earnings Report: Tatva Chintan Pharma Chem Limited Missed Revenue Estimates By 33%

Jul 27
Earnings Report: Tatva Chintan Pharma Chem Limited Missed Revenue Estimates By 33%

Recent updates

Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Price In Tune With Revenues

Sep 26
Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Price In Tune With Revenues

Tatva Chintan Pharma Chem (NSE:TATVA) Has Affirmed Its Dividend Of ₹2.00

Aug 29
Tatva Chintan Pharma Chem (NSE:TATVA) Has Affirmed Its Dividend Of ₹2.00

Earnings Report: Tatva Chintan Pharma Chem Limited Missed Revenue Estimates By 33%

Jul 27
Earnings Report: Tatva Chintan Pharma Chem Limited Missed Revenue Estimates By 33%

Weak Statutory Earnings May Not Tell The Whole Story For Tatva Chintan Pharma Chem (NSE:TATVA)

May 11
Weak Statutory Earnings May Not Tell The Whole Story For Tatva Chintan Pharma Chem (NSE:TATVA)

Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Share Price Matching Investor Opinion

Apr 04
Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Share Price Matching Investor Opinion

These Analysts Just Made A Notable Downgrade To Their Tatva Chintan Pharma Chem Limited (NSE:TATVA) EPS Forecasts

Jan 26
These Analysts Just Made A Notable Downgrade To Their Tatva Chintan Pharma Chem Limited (NSE:TATVA) EPS Forecasts

Tatva Chintan Pharma Chem Limited (NSE:TATVA) Analysts Are Reducing Their Forecasts For This Year

May 10
Tatva Chintan Pharma Chem Limited (NSE:TATVA) Analysts Are Reducing Their Forecasts For This Year

Tatva Chintan Pharma Chem Limited Just Missed Revenue By 15%: Here's What Analysts Think Will Happen Next

Jul 28
Tatva Chintan Pharma Chem Limited Just Missed Revenue By 15%: Here's What Analysts Think Will Happen Next

Getting In Cheap On Tatva Chintan Pharma Chem Limited (NSE:TATVA) Is Unlikely

Jun 17
Getting In Cheap On Tatva Chintan Pharma Chem Limited (NSE:TATVA) Is Unlikely

Investors Shouldn't Be Too Comfortable With Tatva Chintan Pharma Chem's (NSE:TATVA) Robust Earnings

May 03
Investors Shouldn't Be Too Comfortable With Tatva Chintan Pharma Chem's (NSE:TATVA) Robust Earnings

Are Investors Undervaluing Tatva Chintan Pharma Chem Limited (NSE:TATVA) By 45%?

Dec 06
Are Investors Undervaluing Tatva Chintan Pharma Chem Limited (NSE:TATVA) By 45%?

수익 및 매출 성장 예측

NSEI:TATVA - 애널리스트의 미래 추정치 및 과거 재무 데이터 (INR Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
3/31/20277,638931-86102
3/31/20265,807669-5626333
3/31/20254,108148-1314533
9/30/20243,714176-769395N/A
6/30/20243,846261N/AN/AN/A
3/31/20243,935304-305980N/A
12/31/20234,198377N/AN/AN/A
9/30/20234,562459-5901,145N/A
6/30/20234,496452N/AN/AN/A
3/31/20234,236455-1,753278N/A
12/31/20223,976460N/AN/AN/A
9/30/20223,817572-1,480-99N/A
6/30/20224,152825N/AN/AN/A
3/31/20224,336959-689202N/A
12/31/20214,438995N/AN/AN/A
9/30/20214,192976N/AN/AN/A
6/30/20213,557687N/AN/AN/A
3/31/20213,004523-13197N/A
3/31/20202,632378-229253N/A
3/31/20192,063205-2474N/A
3/31/20181,358123N/A126N/A

애널리스트 미래 성장 예측

수입 대 저축률: TATVA's forecast earnings growth (70.5% per year) is above the savings rate (6.7%).

수익 vs 시장: TATVA's earnings (70.5% per year) are forecast to grow faster than the Indian market (18.1% per year).

고성장 수익: TATVA's earnings are expected to grow significantly over the next 3 years.

수익 대 시장: TATVA's revenue (30% per year) is forecast to grow faster than the Indian market (10.2% per year).

고성장 수익: TATVA's revenue (30% per year) is forecast to grow faster than 20% per year.


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: TATVA's Return on Equity is forecast to be low in 3 years time (9.4%).


성장 기업 발견